China will improve its medical insurance policies to boost the development of primary healthcare services in the country, according to the National Healthcare Security Administration (NHSA).
China's five major A-share listed insurance companies achieved a total net profit attributable to the parent company of CNY425.3bn ($62.2bn) in 2025, a year-on-year increase of 22.4%, according to data compiled from their audited annual financial statements.
The bancassurance channel emerged in 2025 as the driver of revenue growth for life insurance companies, particularly listed insurers, according to an analysis of the annual financial statements released by several companies.
The National Financial Regulatory Administration (NFRA) has issued the "Negative List for Personal Insurance Products (2026 Edition)" to all life insurance companies.
The regulatory authorities have issued a notice to the insurance industry that tightens rules on bancassurance fees and improve expense management in life insurance companies.
The National Financial Regulatory Administration (NFRA) has issued a notice, urging insurers to play a pivotal role in rural revitalisation in the country.
Humanoid robot insurance has transitioned from an experimental niche to a specialised sector backed by significant policy momentum. As the Chinese government ramps up its high-tech initiatives, the insurance industry is moving in lockstep to secure the future of "embodied intelligence."
Adult children's biggest concerns about their parents are twofold: lack of care and loneliness, according to the findings of a survey released by Beijing-headquartered e-commerce giant JD.com.
The total number of individual insurance agents across the life operations of five major listed insurers reached 1.33m at the end of December 2025, representing a decrease of 52,000 or 3.7% compared to the end of 2024.
China Reinsurance (Group) Co [China Re Group] has posted consolidated insurance revenue of CNY103.1bn for 2025, 1.7% higher than in 2024. Consolidated total premium income reached CNY180.4bn, a year-on-year increase of 1.1%, according to the company's consolidated financial statements.